Skip to main content
. 2021 Jul 16;17(7):e1009761. doi: 10.1371/journal.ppat.1009761

Fig 5. SARS-CoV-2-specific CD4 and cTfh responses decrease in magnitude in late convalescence.

Fig 5

Frequency of AIM positive CD4 T cells (A) and AIM positive cTfh cells (B) over longitudinal convalescent visits for CID2, CID11, CID12, and CID21.